Filing Details
DataMeds AI, Inc. (NASDAQ:MEDS) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
8k filedNASDAQ:MEDS
DataMeds AI, Inc. (MEDS) Reports Material Event to SEC
DataMeds AI, Inc. (NASDAQ:MEDS) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
At publication ·
What changed
DataMeds AI, Inc. (NASDAQ:MEDS) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- DataMeds AI, Inc. (NASDAQ:MEDS) filed a Form 8-K with the SEC on August 18, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $1.38 with a market capitalization of $13.3 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
DataMeds AI, Inc.'s stock currently trades at $1.38 with a market capitalization of $13.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for DataMeds AI, Inc.'s stock.
All SEC filings for DataMeds AI, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MEDS Stock Page
Frequently Asked Questions
Where can I read MEDS's SEC filings?
Browse all filings on our MEDS SEC filings page.
What types of SEC filings does DataMeds AI, Inc. file?
Public companies like DataMeds AI, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.